Hepatocellular carcinoma mainly displays CTNNB1 mutations (20–35%) [29], AXIN1 mutations (8–15%) [30], and Frizzled-7 (FZD7) overexpression (90%) [31]. This evidence concerns the gene FZD7 and hepatocellular carcinoma.